🔎 Trials Near Me

ホーム › 肥満症 › アリゾナ州 › Phoenix

Phoenix、AZにおける肥満症の臨床試験

Phoenixとその周辺地域(約30マイル以内)の拠点で、肥満症に関する22件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

Early Tracking of Childhood Health Determinants (ETCHED) Study

被験者募集中観察研究健康なボランティア歓迎
  • NIDDK, Phoenix, Phoenix
1 Day – 99 Years · 全性別 · 2026/09/28更新 · NCT03481829

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

被験者募集中第3相
  • RIO Clinical Trials - Phoenix, Phoenix
18歳以上 · 全性別 · 2026/09/22更新 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

被験者募集中第3相
  • Research Site, Phoenix
18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

被験者募集中第3相
  • Synexus Clinical Research US, Inc., Phoenix
  • Medical Advancement Centers of Arizona, Phoenix
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

被験者募集中第3相
  • Elite Clinical Studies, LLC, Phoenix
18歳以上 · 全性別 · 2026/09/22更新 · NCT07353931

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

被験者募集中健康なボランティア歓迎
  • NIDDK, Phoenix, Phoenix
18歳〜99歳 · 全性別 · 2026/09/21更新 · NCT06223555

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

被験者募集中第3相
  • AURORA-1 Clinical Site, Phoenix
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

被験者募集中第3相
  • AURORA-2 Clinical Site, Phoenix
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

被験者募集中第3相
  • HonorHealth, Phoenix
  • Medical Advancement Centers of Arizona, Phoenix
18歳〜99歳 · 全性別 · 2026/09/16更新 · NCT07037459

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

被験者募集中第2相
  • Helios Clinical Research - Phoenix, Phoenix
18歳〜75歳 · 全性別 · 2026/09/14更新 · NCT06897475

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

被験者募集中第3相健康なボランティア歓迎
  • ACCOMPLISH-2 Research Site, Phoenix
18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

被験者募集中第2相
  • Synexus Clinical Research US, Inc., Phoenix
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT07215559

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

被験者募集中第3相
  • Kailera Clinical Site, Phoenix
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284901

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

被験者募集中第3相
  • Kailera Clinical Site, Phoenix
18歳以上 · 全性別 · 2026/09/01更新 · NCT07284979

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

被験者募集中健康なボランティア歓迎
  • NIDDK, Phoenix, Phoenix
18歳〜60歳 · 全性別 · 2026/08/28更新 · NCT05545306

Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity

被験者募集中観察研究
  • Exponent Phoenix, Phoenix
18歳以上 · 全性別 · 2026/08/20更新 · NCT07776678

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

被験者募集中第3相
  • Honor Health, Phoenix
  • Arizona Research Center, Phoenix
18歳以上 · 全性別 · 2026/08/18更新 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

被験者募集中第3相
  • ACCOMPLISH-1 Research Site, Phoenix
18歳〜79歳 · 全性別 · 2026/08/10更新 · NCT07654361

Fibrosis Lessens After Metabolic Surgery

被験者募集中第4相健康なボランティア歓迎
  • Banner Health Center, Phoenix
18歳〜75歳 · 全性別 · 2026/07/31更新 · NCT06374875

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

被験者募集中第3相
  • Arizona Research Center, Inc., Phoenix
18歳以上 · 全性別 · 2026/07/09更新 · NCT07481630

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

被験者募集中第3相
  • The University of Arizona College of Medicine- Phoenix, Phoenix
18歳〜75歳 · 全性別 · 2025/11/14更新 · NCT06499857

他の都市における肥満症の試験

Phoenixにおける他の研究

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。